vs
雅培(ABT)与National Vision Holdings, Inc.(EYE)财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是National Vision Holdings, Inc.的23.5倍($11.5B vs $487.3M)。雅培净利率更高(15.5% vs 0.7%,领先14.8%)。National Vision Holdings, Inc.同比增速更快(7.9% vs 4.4%)。雅培自由现金流更多($2.6B vs $30.3M)。过去两年National Vision Holdings, Inc.的营收复合增速更高(7.6% vs 7.2%)
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业,业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块,在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
Vision Research是一家总部位于美国新泽西州韦恩的跨国企业,主营高速数码相机的研发生产,旗下产品以Phantom品牌推向市场,广泛应用于国防、工业产品开发、制造、汽车、科研、娱乐等众多领域,目前隶属于全球电子仪器及机电设备制造商阿美特克公司的材料分析事业部。
ABT vs EYE — 直观对比
营收规模更大
ABT
是对方的23.5倍
$487.3M
营收增速更快
EYE
高出3.5%
4.4%
净利率更高
ABT
高出14.8%
0.7%
自由现金流更多
ABT
多$2.6B
$30.3M
两年增速更快
EYE
近两年复合增速
7.2%
损益表 — Q4 2025 vs Q3 2026
| 指标 | ||
|---|---|---|
| 营收 | $11.5B | $487.3M |
| 净利润 | $1.8B | $3.4M |
| 毛利率 | 57.0% | — |
| 营业利润率 | 19.6% | 2.0% |
| 净利率 | 15.5% | 0.7% |
| 营收同比 | 4.4% | 7.9% |
| 净利润同比 | -80.8% | 139.8% |
| 每股收益(稀释后) | $1.01 | $0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ABT
EYE
| Q4 25 | $11.5B | — | ||
| Q3 25 | $11.4B | $487.3M | ||
| Q2 25 | $11.1B | $486.4M | ||
| Q1 25 | $10.4B | $510.3M | ||
| Q4 24 | $11.0B | $437.3M | ||
| Q3 24 | $10.6B | $451.5M | ||
| Q2 24 | $10.4B | $451.7M | ||
| Q1 24 | $10.0B | $482.8M |
净利润
ABT
EYE
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.6B | $3.4M | ||
| Q2 25 | $1.8B | $8.7M | ||
| Q1 25 | $1.3B | $14.2M | ||
| Q4 24 | $9.2B | $-28.6M | ||
| Q3 24 | $1.6B | $-8.5M | ||
| Q2 24 | $1.3B | $-3.1M | ||
| Q1 24 | $1.2B | $11.7M |
毛利率
ABT
EYE
| Q4 25 | 57.0% | — | ||
| Q3 25 | 55.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 55.6% | — | ||
| Q1 24 | 55.2% | — |
营业利润率
ABT
EYE
| Q4 25 | 19.6% | — | ||
| Q3 25 | 18.1% | 2.0% | ||
| Q2 25 | 18.4% | 3.4% | ||
| Q1 25 | 16.3% | 5.1% | ||
| Q4 24 | 17.4% | -5.8% | ||
| Q3 24 | 17.5% | -2.0% | ||
| Q2 24 | 16.1% | 0.1% | ||
| Q1 24 | 13.9% | 4.9% |
净利率
ABT
EYE
| Q4 25 | 15.5% | — | ||
| Q3 25 | 14.5% | 0.7% | ||
| Q2 25 | 16.0% | 1.8% | ||
| Q1 25 | 12.8% | 2.8% | ||
| Q4 24 | 84.1% | -6.5% | ||
| Q3 24 | 15.5% | -1.9% | ||
| Q2 24 | 12.5% | -0.7% | ||
| Q1 24 | 12.3% | 2.4% |
每股收益(稀释后)
ABT
EYE
| Q4 25 | $1.01 | — | ||
| Q3 25 | $0.94 | $0.04 | ||
| Q2 25 | $1.01 | $0.11 | ||
| Q1 25 | $0.76 | $0.18 | ||
| Q4 24 | $5.26 | $-0.36 | ||
| Q3 24 | $0.94 | $-0.11 | ||
| Q2 24 | $0.74 | $-0.04 | ||
| Q1 24 | $0.70 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $56.0M |
| 总债务越低越好 | $12.9B | $236.5M |
| 股东权益账面价值 | $52.1B | $858.8M |
| 总资产 | $86.7B | $2.0B |
| 负债/权益比越低杠杆越低 | 0.25× | 0.28× |
8季度趋势,按日历期对齐
现金及短期投资
ABT
EYE
| Q4 25 | $8.9B | — | ||
| Q3 25 | $7.7B | $56.0M | ||
| Q2 25 | $7.3B | $48.5M | ||
| Q1 25 | $6.8B | $80.0M | ||
| Q4 24 | $8.0B | $73.9M | ||
| Q3 24 | $7.8B | $81.2M | ||
| Q2 24 | $7.2B | $179.5M | ||
| Q1 24 | $6.7B | $150.1M |
总债务
ABT
EYE
| Q4 25 | $12.9B | — | ||
| Q3 25 | — | $236.5M | ||
| Q2 25 | — | $255.6M | ||
| Q1 25 | — | $244.7M | ||
| Q4 24 | $14.1B | $248.6M | ||
| Q3 24 | — | $252.8M | ||
| Q2 24 | — | $143.9M | ||
| Q1 24 | — | $448.6M |
股东权益
ABT
EYE
| Q4 25 | $52.1B | — | ||
| Q3 25 | $51.0B | $858.8M | ||
| Q2 25 | $50.6B | $850.6M | ||
| Q1 25 | $48.8B | $836.2M | ||
| Q4 24 | $47.7B | $816.3M | ||
| Q3 24 | $39.8B | $840.0M | ||
| Q2 24 | $39.3B | $843.4M | ||
| Q1 24 | $38.8B | $841.3M |
总资产
ABT
EYE
| Q4 25 | $86.7B | — | ||
| Q3 25 | $84.2B | $2.0B | ||
| Q2 25 | $84.0B | $2.0B | ||
| Q1 25 | $81.4B | $2.0B | ||
| Q4 24 | $81.4B | $2.0B | ||
| Q3 24 | $74.4B | $2.0B | ||
| Q2 24 | $73.0B | $2.1B | ||
| Q1 24 | $72.5B | $2.2B |
负债/权益比
ABT
EYE
| Q4 25 | 0.25× | — | ||
| Q3 25 | — | 0.28× | ||
| Q2 25 | — | 0.30× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | 0.30× | 0.30× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $3.3B | $46.6M |
| 自由现金流经营现金流 - 资本支出 | $2.6B | $30.3M |
| 自由现金流率自由现金流/营收 | 22.9% | 6.2% |
| 资本支出强度资本支出/营收 | 6.0% | 3.4% |
| 现金转化率经营现金流/净利润 | 1.87× | 13.83× |
| 过去12个月自由现金流最近4个季度 | $7.4B | $83.0M |
8季度趋势,按日历期对齐
经营现金流
ABT
EYE
| Q4 25 | $3.3B | — | ||
| Q3 25 | $2.8B | $46.6M | ||
| Q2 25 | $2.0B | $54.3M | ||
| Q1 25 | $1.4B | $32.2M | ||
| Q4 24 | $2.9B | $30.3M | ||
| Q3 24 | $2.7B | $27.9M | ||
| Q2 24 | $2.0B | $51.5M | ||
| Q1 24 | $1.0B | $24.0M |
自由现金流
ABT
EYE
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.3B | $30.3M | ||
| Q2 25 | $1.5B | $42.4M | ||
| Q1 25 | $933.0M | $12.0M | ||
| Q4 24 | $2.1B | $-1.7M | ||
| Q3 24 | $2.1B | $4.1M | ||
| Q2 24 | $1.4B | $31.9M | ||
| Q1 24 | $627.0M | $4.0M |
自由现金流率
ABT
EYE
| Q4 25 | 22.9% | — | ||
| Q3 25 | 20.2% | 6.2% | ||
| Q2 25 | 13.9% | 8.7% | ||
| Q1 25 | 9.0% | 2.4% | ||
| Q4 24 | 19.6% | -0.4% | ||
| Q3 24 | 20.2% | 0.9% | ||
| Q2 24 | 13.8% | 7.1% | ||
| Q1 24 | 6.3% | 0.8% |
资本支出强度
ABT
EYE
| Q4 25 | 6.0% | — | ||
| Q3 25 | 4.4% | 3.4% | ||
| Q2 25 | 4.5% | 2.4% | ||
| Q1 25 | 4.7% | 4.0% | ||
| Q4 24 | 6.6% | 7.3% | ||
| Q3 24 | 5.2% | 5.3% | ||
| Q2 24 | 5.1% | 4.3% | ||
| Q1 24 | 4.0% | 4.1% |
现金转化率
ABT
EYE
| Q4 25 | 1.87× | — | ||
| Q3 25 | 1.70× | 13.83× | ||
| Q2 25 | 1.15× | 6.22× | ||
| Q1 25 | 1.07× | 2.27× | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 1.64× | — | ||
| Q2 24 | 1.51× | — | ||
| Q1 24 | 0.84× | 2.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图